FDA Approved: ALOGLIPTIN AND PIOGLITAZONE — Original Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved a fixed-dose combination product containing alogliptin and pioglitazone from Padagis Israel Pharmaceuticals Ltd for type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Alogliptin and pioglitazone (Alogliptin benzoate and pioglitazone hydrochloride)

Snippet

ORIG AP for ALOGLIPTIN AND PIOGLITAZONE (ALOGLIPTIN BENZOATE AND PIOGLITAZONE HYDROCHLORIDE)